Endogenous Heparinoids May Cause Bleeding in Mucor Infection and can be Detected by Nonactivated Thromboelastometry and Treated by Recombinant Activated Factor VII: A Case Report
Language English Country United States Media print
Document type Case Reports, Journal Article, Research Support, Non-U.S. Gov't
PubMed
26937941
PubMed Central
PMC4779038
DOI
10.1097/md.0000000000002933
PII: 00005792-201602230-00058
Knihovny.cz E-resources
- MeSH
- Antifungal Agents therapeutic use MeSH
- Child MeSH
- Drainage adverse effects MeSH
- Factor VIIa therapeutic use MeSH
- Heparinoids metabolism MeSH
- Iatrogenic Disease MeSH
- Hemorrhage etiology therapy MeSH
- Humans MeSH
- Mucormycosis drug therapy metabolism MeSH
- Recombinant Proteins therapeutic use MeSH
- Spleen injuries surgery MeSH
- Splenectomy MeSH
- Blood Coagulation Tests * MeSH
- Check Tag
- Child MeSH
- Humans MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Antifungal Agents MeSH
- Factor VIIa MeSH
- Heparinoids MeSH
- recombinant FVIIa MeSH Browser
- Recombinant Proteins MeSH
Mucormycosis is an aggressive fungal infection, which invades endothelial cells of blood vessels. This condition might lead to destruction of endothelium and release of heparin-like substances to the bloodstream and cause life-threatening bleeding, which is not well described in the literature.We present a patient with mucormycosis who experienced life-threatening bleeding, although no standard laboratory test could detect any coagulopathy.The cause of bleeding-coagulopathy was detected only by nonactivated thromboelastometry (NATEM), which revealed the presence of heparin-like substances. After treatment with recombinant activated FVII rotational thromboelastometry, results improved and the patient stopped bleeding. Regular application of the drug was necessary during acute phase of infection to prevent further bleeding.In this case report, we show that NATEM can detect the presence of heparin-like substances in bleeding patient with mucormycosis infection and that recombinant activated FVII can be used to stop and prevent bleeding until infection resolves.
See more in PubMed
Durila M, Lukas P, Bronsky J, et al. Time impact on non-activated and kaolin-activated blood samples in thromboelastography. BMC Anesthesiol 2015; 15:50. PubMed PMC
Bowbrick VA, Mikhailidis DP, Stansby G. The use of citrated whole blood in thromboelastography. Anesth Analg 2000; 90:1086–1088. PubMed
Durila M. Nonactivated thromboelastometry able to detect fibrinolysis in contrast to activated methods (EXTEM, INTEM) in a bleeding patient. Blood Coagul Fibrinolysis 2015; [Epub ahead of print] PMID: 26656899. PubMed
Ibrahim AS, Spellberg B, Avanessian V, et al. Rhizopus oryzae adheres to, is phagocytosed by, and damages endothelial cells in vitro. Infect Immun 2005; 73:778–783. PubMed PMC
Senzolo M, Coppell J, Cholongitas E, et al. The effects of glycosaminoglycans on coagulation: a thromboelastographic study. Blood Coagul Fibrinolysis 2007; 18:227–236. PubMed
Durila M, Bures J, Pelichovska M, et al. Hypocoagulation state in severe systemic inflammatory response syndrome/sepsis is consistent with endogenous heparinoid effect as detected by thromboelastography. Anaesth Intensive Care 2011; 39:508–509. PubMed
Montalto P, Vlachogiannakos J, Cox DJ, et al. Bacterial infection in cirrhosis impairs coagulation by a heparin effect: a prospective study. J Hepatol 2002; 37:463–470. PubMed
Durila M. Kaolin activated thromboelastography can result in false positive fibrinolytic trace. Anaesth Intensive Care 2011; 39:775–776. PubMed